Celebrex-Lipitor combination may halt prostate cancer, U.S. researchers find

April 15th, 2008 | by admin |

Administering a combination of the widely used drugs Celebrex, an anti-inflammatory drug, and Lipitor, a cholesterol-lowering drug, stops the transition of early prostate cancer to its more aggressive and potentially fatal stage, according …

Tags: , ,

Related posts

Sorry, comments for this entry are closed at this time.